NO20005059D0 - Nye behandlinger for nervøse lidelser - Google Patents

Nye behandlinger for nervøse lidelser

Info

Publication number
NO20005059D0
NO20005059D0 NO20005059A NO20005059A NO20005059D0 NO 20005059 D0 NO20005059 D0 NO 20005059D0 NO 20005059 A NO20005059 A NO 20005059A NO 20005059 A NO20005059 A NO 20005059A NO 20005059 D0 NO20005059 D0 NO 20005059D0
Authority
NO
Norway
Prior art keywords
disorders
addiction
new treatments
nervous disorders
reboxetine
Prior art date
Application number
NO20005059A
Other languages
English (en)
Other versions
NO20005059L (no
Inventor
Fred Hassan
John Michael Mccall
Duncan Paul Taylor
Philip F Von Voigtlander
Erik Ho Fong Wong
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of NO20005059D0 publication Critical patent/NO20005059D0/no
Publication of NO20005059L publication Critical patent/NO20005059L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Addiction (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Anesthesiology (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO20005059A 1998-04-09 2000-10-06 Nye behandlinger for nervøse lidelser NO20005059L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8123198P 1998-04-09 1998-04-09
PCT/US1999/004289 WO1999052531A1 (en) 1998-04-09 1999-04-02 New treatments for nervous disorders

Publications (2)

Publication Number Publication Date
NO20005059D0 true NO20005059D0 (no) 2000-10-06
NO20005059L NO20005059L (no) 2000-10-06

Family

ID=22162900

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20005059A NO20005059L (no) 1998-04-09 2000-10-06 Nye behandlinger for nervøse lidelser

Country Status (24)

Country Link
US (1) US6352986B1 (no)
EP (1) EP1069900B1 (no)
JP (1) JP2002511414A (no)
KR (1) KR20010034758A (no)
CN (1) CN1301164A (no)
AT (1) ATE301462T1 (no)
AU (1) AU756373B2 (no)
BR (1) BR9909478A (no)
CA (2) CA2634698A1 (no)
CZ (1) CZ297346B6 (no)
DE (1) DE69926616T2 (no)
DK (1) DK1069900T3 (no)
EA (1) EA200001049A1 (no)
ES (1) ES2244189T3 (no)
HU (1) HUP0102436A3 (no)
IL (1) IL138855A0 (no)
NO (1) NO20005059L (no)
NZ (1) NZ507398A (no)
PL (1) PL193797B1 (no)
PT (1) PT1069900E (no)
SK (1) SK14492000A3 (no)
TR (1) TR200002868T2 (no)
WO (1) WO1999052531A1 (no)
ZA (1) ZA200004454B (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6586427B2 (en) * 1998-04-09 2003-07-01 Pharmacia & Upjohn Company Treatments for nervous disorders
SI1196172T1 (sl) * 1999-07-01 2006-06-30 Pharmacia & Upjohn Co Llc (S,S)-reboksetin za zdravljenje kronicne bolecine
US6465458B1 (en) * 1999-07-01 2002-10-15 Pharmacia & Upjohn Company Method of treating or preventing chronic pain with a highly selective norepinephrine reuptake inhibitor
AU4529101A (en) * 2000-03-07 2001-09-17 Eli Lilly And Company Treatment of psoriasis
SE521512C2 (sv) 2001-06-25 2003-11-11 Niconovum Ab Anordning för administrering av en substans till främre delen av en individs munhåla
US20040102440A1 (en) * 2002-07-01 2004-05-27 Wong Erik Ho Fong Method of promoting smoking cessation
ES2285233T3 (es) 2002-12-20 2007-11-16 Niconovum Ab Un material en particulas que contiene nicotina y celulosa microcristalina fisicamente y quimicamente estable.
UA95454C2 (uk) 2005-07-15 2011-08-10 Амр Текнолоджи, Інк. Арил- і гетероарилзаміщені тетрагідробензазепіни і їх застосування для блокування зворотного захоплення норепінефрину, допаміну і серотоніну
US9402809B2 (en) 2006-03-16 2016-08-02 Niconovum Usa, Inc. Snuff composition
US20100069389A1 (en) * 2008-09-06 2010-03-18 Bionevia Pharmaceuticals, Inc. Novel forms of reboxetine
AU2010247763B2 (en) 2009-05-12 2015-12-24 Albany Molecular Research, Inc. 7-([1,2,4,]triazolo[1,5,-a]pyridin-6-yl)-4-(3,4-dichlorophenyl)-1,2,3,4- tetrahydroisoquinoline and use thereof
US8815894B2 (en) 2009-05-12 2014-08-26 Bristol-Myers Squibb Company Crystalline forms of (S)-7-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydroisoquinoline and use thereof
WO2012024397A2 (en) 2010-08-17 2012-02-23 Albany Molecular Research, Inc. 2,5-methano-and 2,5-ethano-tetrahydrobenzazepine derivatives and use thereof to block reuptake of norepinephrine, dopamine, and serotonin

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL56369A (en) 1978-01-20 1984-05-31 Erba Farmitalia Alpha-phenoxybenzyl propanolamine derivatives,their preparation and pharmaceutical compositions comprising them
EP0072177B1 (en) * 1981-08-07 1987-01-07 Holset Engineering Company Limited Impeller for centrifugal compressor
GB8419683D0 (en) 1984-08-02 1984-09-05 Erba Farmitalia 3-substituted derivatives of 1-amino-2-hydroxy-propane
US5281624A (en) * 1991-09-27 1994-01-25 Eli Lilly And Company N-alkyl-3-phenyl-3-(2-substituted phenoxy) propylamines and pharmaceutical use thereof
ZA958725B (en) * 1994-10-20 1997-04-16 Lilly Co Eli Treatment of disorders with duloxetine
US5658590A (en) * 1995-01-11 1997-08-19 Eli Lilly And Company Treatment of attention-deficit/hyperactivity disorder
NZ313076A (en) * 1995-07-24 1999-11-29 Lilly Co Eli Medicament containing duloxetine for treating hyperactivity and attention deficiency disorders
AU9214498A (en) * 1997-09-23 1999-04-12 Eli Lilly And Company Treatment of attention-deficit/hyperactivity disorder
UA56257C2 (uk) 1997-09-23 2003-05-15 Елі Ліллі Енд Компані Спосіб лікування неадекватної визивної поведінки

Also Published As

Publication number Publication date
ES2244189T3 (es) 2005-12-01
EP1069900B1 (en) 2005-08-10
IL138855A0 (en) 2001-10-31
AU3449499A (en) 1999-11-01
CZ20003671A3 (en) 2001-06-13
BR9909478A (pt) 2000-12-19
TR200002868T2 (tr) 2001-01-22
ATE301462T1 (de) 2005-08-15
HUP0102436A3 (en) 2002-01-28
EP1069900A1 (en) 2001-01-24
JP2002511414A (ja) 2002-04-16
DK1069900T3 (da) 2005-10-31
KR20010034758A (ko) 2001-04-25
CA2634698A1 (en) 1999-10-21
PL193797B1 (pl) 2007-03-30
PT1069900E (pt) 2005-10-31
EA200001049A1 (ru) 2001-04-23
CZ297346B6 (cs) 2006-11-15
DE69926616T2 (de) 2006-05-24
NO20005059L (no) 2000-10-06
HUP0102436A2 (hu) 2001-11-28
CA2321157A1 (en) 1999-10-21
PL346293A1 (en) 2002-01-28
WO1999052531A1 (en) 1999-10-21
SK14492000A3 (sk) 2001-06-11
AU756373B2 (en) 2003-01-09
US6352986B1 (en) 2002-03-05
NZ507398A (en) 2004-01-30
DE69926616D1 (de) 2005-09-15
CN1301164A (zh) 2001-06-27
ZA200004454B (en) 2002-04-24

Similar Documents

Publication Publication Date Title
MY127739A (en) Use of pramipexole for the treatment of addictive disorders
NO20005059D0 (no) Nye behandlinger for nervøse lidelser
TW200607510A (en) Use of optically pure (s.s)-reboxetine in the manufacture of a medicament for the treatment or prevention of fibromyalgia or another somatoform disorder
BR0205722A (pt) Formulação de liberação prolongada e método para o tratamento de um paciente que sofre de dor
ES2164040T1 (es) Uso de agonistas del sitio de union de la glicina o de inhibidores de la absorcion de la glicina para el tratamiento de trastornos neuropsiquiatricos.
GEP20043269B (en) Purine Derivatives, Method for Their Production and Composition Containing the Same
BG106095A (bg) Нови лекарствени състави на базата на антихолинергично активни съединения и бета-миметици
IL164291A0 (en) Medicaments containing betamimetic drugs and a novel anticholinesterase drug
DK0796103T3 (da) Anvendelse af røgelse til behandling af Alzheimer-sygdommen
DE69424777D1 (de) 3,4-diarylchromane zur behandlung von dermatitis
MX2024006271A (es) Nuevas combinaciones terapeuticas para el tratamiento de enfermedades pulmonares intersticiales fibrosantes progresivas.
BR0313411A (pt) Uso de reboxetina para o tratamento de ondas de calor
AR030364A1 (es) Compuestos para el tratamiento de desordenes adictivos
NO20005131L (no) Nye behandlinger for nervøse forstyrrelser
EE200200549A (et) Jagatud doosi teraapia veresooni kahjustava aktiivsusega
DE69910242D1 (de) Verwendung eines Nikotin-Rezeptor Agonisten zur Herstellung eines Medikaments zur Behandlung von Zwangsneurosen
BR0316192A (pt) Método e composições para o tratamento da ansiedade
Fagerstrom E-25. Effective treatments for smoking: Established and experimental approaches
TH53106A (th) การใช้พรามิพิโซลสำหรับการรักษาอาการผิดปกติจากการติดยา
RU2004109518A (ru) Способ лечения табачной зависимости
RU2001102089A (ru) Способ лечения дисциркуляторной энцефалопатии
CA2532330A1 (en) Highly selective norepinephrine reuptake inhibitors and methods of using the same

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application